Tumour-associated bacteria co-migrate to m...The same bacteria present in primary tumours of patients with colorectal cancer are also present in liver metastases, according to a new study. What’s more, presence of the bacteria was found to correlate … more ➔
Philips leads €6.3m EU liquid biopsy con...The EU is investing another €6.3m into the blood diagnosis of primary breast cancer and rectal cancer. In the 4-year LIMA project, Royal Philips will lead a SME consortium that combines liquid … more ➔
Heidelberg Pharma AG raises €34.4mAntibody-drug-conjugate (ADC) specialist Heidelberg Pharma AG has raised €34.4m through the issuance of 7,484,190 new shares at €2.60 and 14,968,380 convertible bonds with a nominal value of €1 … more ➔
Amsterdam applauded as new EMA headquarter...Amsterdam has beaten Milan and Copenhagen in the race to become the European Medicines Agency’s new home. Pharma and biotech stakeholders applauded the vote as Amsterdam achieved the hightest rate of … more ➔
Roche chemo-immunotherapy combo meet NSCLC... A Phase III study (IMpower150) sponsored by Roche has shown that a combo of the company’s PD-L1 blocker atezolizumab (Tecentriq) and VEGF blocking antibody bevacizumab (Avastin) plus paclitaxel + carboplatin … more ➔
Orphazyme raises €80m in oversubscribed...Danish heat shock protein specialist Orphazyme raised €80m+ through an IPO at Nasdaq Copenhagen adding momentum to the current upswing of European biotech. more ➔
Antibiotic Resistance: EU SME alliance cal...The BEAM Alliance has called out worldwide stakeholders to support SME-driven innovation to revive the product pipeline fighting antimicrobial resistance (AMR). In a position paper the alliance … more ➔
Bayer inks US$1.55bn cancer deal with Loxo...German Bayer AG has acquired ex-US commercialisation rights to Loxo Oncology Inc’s Phase II lead larotrectinib (LOXO-101), which targets TRK (tropomyosin receptor kinase) fusions in 17 cancer types, … more ➔
Bill Gates invests into Alzheimer’s... Billionaire Bill Gates announced he is going to invest US$50m private money into the Dementia Discovery Fund (DDF) to support fresh ideas for developing Alzheimer drugs and diagnostics. The venture … more ➔
CHMP recommends EU marketing approval of...The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended seven medicines for approval, including two orphan medicines, plus three generics at its November 2017 … more ➔
